Statins May Reduce Contrast-Induced Acute Kidney Injury
Given the widespread use of contrast medium in cardiovascular and other imaging, continued focus on preventing contrast-induced acute kidney injury is warranted.
Diagnosis & Disease Information
Post-Contrast Acute Kidney Injury Linked to Transient Hypotension
Transient hypotension increases the risk for post-contrast acute kidney injury following computed tomography with contrast media, according to investigators.
Intervention Cuts Risk for AKI After Coronary Angiography
Reduced incidence of AKI seen in association with multifaceted intervention, including clinical decision support, audit, feedback
Study: RenalGuard Not Superior in Avoiding CIN in High-Risk Cases
Latest findings from a study of RenalGuard contrast with those of previous randomized controlled trials.
Allopurinol May Reduce Contrast Nephropathy in CKD Population
Previous research suggested that allopurinol, a xanthine oxidase inhibitor, prevents the formation of oxygen-free radicals that may contribute to contrast nephropathy.
Markers to Predict CI-AKI in Patients With ACS Undergoing Coronary Angiography
BNP or NT-proBNP may represent effective markers for the prediction of contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing coronary angiography.
Gadavist Imaging Bulk Package Approved for Multi-Patient Dosing
Gadavist® Imaging Bulk Package is supplied as 604.72mg/mL of gadobutrol in 30mL and 65mL multidose containers.
Recommendations for Use of IV Iodinated Contrast Media Updated
Radiologists and clinicians should weigh the relative benefits and risks of using IV contrast in patients with eGFRs less than 30 mL/min/1.73 m2, according to a consensus statement.
Renal Outcomes Not Worsened by Omitting Hydration Prior to Contrast-Enhanced CT
Withholding prehydration with sodium bicarbonate from patients with CKD stage 3 undergoing nonemergent contrast-enhanced computed tomography does not compromise renal safety, a study found.
Data Support Group II Gadolinium-Based Contrast Use in Advanced Kidney Disease
The potential diagnostic harms of withholding group II gadolinium-based contrast agents may outweigh the risk of nephrogenic systemic fibrosis in advanced CKD patients, according to investigators.
- Loading...
Loading...
Next post in Contrast Nephropathy
Loading... 
Loading...